Agape ATP (ATPC)
NASDAQ:ATPC
US Market

Agape ATP (ATPC) Stock Price & Analysis

7 Followers

ATPC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.06 - $18.00
Previous Close$1.41
Volume163.39K
Average Volume (3M)380.92K
Market Cap
$106.39M
Enterprise Value$105.05M
Total Cash (Recent Filing)$1.44M
Total Debt (Recent Filing)$82.71K
Price to Earnings (P/E)-60.0
Beta-0.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding75,452,012
10 Day Avg. Volume668,244
30 Day Avg. Volume380,916
Standard Deviation0.14
R-Squared0.07
Alpha0.00722
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue56.58
Enterprise Value/Gross Profit88.24
Enterprise Value/Ebitda-79.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ATPC FAQ

What was Agape ATP’s price range in the past 12 months?
Agape ATP lowest stock price was $1.06 and its highest was $18.00 in the past 12 months.
    What is Agape ATP’s market cap?
    Currently, no data Available
    When is Agape ATP’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Agape ATP’s earnings last quarter?
    Currently, no data Available
    Is Agape ATP overvalued?
    According to Wall Street analysts Agape ATP’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Agape ATP pay dividends?
      Agape ATP does not currently pay dividends.
      What is Agape ATP’s EPS estimate?
      Agape ATP’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Agape ATP have?
      Agape ATP has 75,452,010 shares outstanding.
        What happened to Agape ATP’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Agape ATP?
        Currently, no hedge funds are holding shares in ATPC

        ---

        Agape ATP Stock Smart Score

        5
        Neutral
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        -64.83%
        12-Months-Change

        Fundamentals

        Return on Equity
        -108.48%
        Trailing 12-Months
        Asset Growth
        -45.40%
        Trailing 12-Months
        The Agape ATP stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
        Learn more about TipRanks Smart Score

        Company Description

        Agape ATP

        Agape ATP Corp. engages in the provision of health solution advisory services. It also supplies health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, and anti-aging. The company was founded by How Kok Choong on June 1, 2016 and is headquartered in Kuala Lumpur, Malaysia.

        ---

        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Company
        Price & Change
        Follow
        American Assets
        Acro Biomedical Co

        Popular Stocks

        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis